David Patience - Feb 26, 2025 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Chief Financial Officer
Signature
/s/ David Patience
Stock symbol
AXDX
Transactions as of
Feb 26, 2025
Transactions value $
-$583
Form type
4
Date filed
2/27/2025, 07:24 PM
Previous filing
May 30, 2024
Next filing
Apr 2, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Options Exercise $0 +1.5K +2.98% $0.00 51.9K Feb 26, 2025 Direct F1
transaction AXDX Common Stock Sale -$583 -535 -1.03% $1.09 51.4K Feb 26, 2025 Direct F2
holding AXDX Common Stock 760 Feb 26, 2025 By Spouse IRA

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXDX Employee Restricted Stock Units Options Exercise $0 -1.5K -100% $0.00 0 Feb 26, 2025 Common Stock 1.5K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock upon vesting.
F2 The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
F3 On February 26, 2022, the reporting person was granted a total of 2,500 RSUs, of which 40% vest on February 26, 2024 and the remaining 60% vest on February 26, 2025.